Unlock instant, AI-driven research and patent intelligence for your innovation.

A targeting peptide based on subunit b of human calmodulin phosphatase, preparation method and application thereof

A targeting peptide and targeting technology, applied in the field of biomedicine, can solve problems such as increasing the risk of squamous cell carcinoma

Active Publication Date: 2021-07-30
BEIJING MEDINTELL BIOMED CO LTD +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The basic function of CNB is to regulate the catalytic activity of CNA, but more and more studies have shown that CNB has a physiological role independent of CN, and the absence of CNB will increase the risk of squamous cell carcinoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A targeting peptide based on subunit b of human calmodulin phosphatase, preparation method and application thereof
  • A targeting peptide based on subunit b of human calmodulin phosphatase, preparation method and application thereof
  • A targeting peptide based on subunit b of human calmodulin phosphatase, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Example 1 Expression of Targeted Peptide Fusion Protein

[0066] 1. Structure design of targeted peptide fusion protein

[0067] The structural schematic diagram of the targeting peptide fusion protein is as follows figure 1 As shown, GFP is located at the N-terminus of the fusion protein, and the full-length CNB or CNB truncations of different lengths are located at the C-terminus of the fusion protein, and the middle is connected with the GGGSGGGS linker. The number of amino acids contained in each CNB truncated body and the distribution of amino acids in the full-length CNB are shown in the figure. The full-length CNB contained by GFP-CNB has the amino acid sequence of positions 1-170 (as shown in SEQ ID NO. 3); the CNB truncated body Trun1 contained by GFP-Trun1 has the amino acid sequence of positions 1-85 of the full-length CNB; The CNB truncated body Trun2 contained by GFP-Trun2 has the amino acid sequence of the 86th-170th position of the full-length CNB; the ...

Embodiment 2

[0075] Example 2 Targeted transport of targeting peptides in animals

[0076] 1. Establishment of tumor animal model

[0077] The purchased Balb / c 5-6-week-old female nude mice were randomly divided into groups and inoculated subcutaneously with 2*10 6 HepG2 tumor cells were placed in the armpits of mice, and when the tumors grew to the size of soybeans, about 200-500mm 3 , the experiment can be performed.

[0078] 2. Fluorescent labeling of targeting peptides

[0079] The cyanine dye Cy7 was selected as the fluorescent substance, and the Trun3 truncated body (which could be chemically synthesized) and the full-length CNB (which could be chemically synthesized) were labeled according to conventional techniques, and the labeled targeting peptide was used for targeting research.

[0080] 3. Real-time fluorescent quantitative detection of targeting peptides

[0081] The mice were divided into 3 groups, the blank control group (1), the positive control CNB-Cy7 (4), and the exp...

Embodiment 3

[0082] Example 3 Targeted delivery of anti-tumor targeted drugs

[0083] According to the experimental results of the previous examples, it can be concluded that Trun3 and Trun6 can be used as targeted transport peptides to bring other substances into tumor cells or tumor tissues. Therefore, antitumor drugs can be linked to Trun3 or Trun6, and they can be injected intravenously, Orally or in other ways, it is introduced into the body of tumor patients, so that anti-tumor drugs can target tumor tissues, specifically kill tumor cells, and reduce the side effects of tumor treatment drugs.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a novel targeting peptide, which is a CNB-based truncation body. At the same time, the invention discloses a preparation method of using Trun3 as a targeting peptide to transport anti-tumor drugs, which is used for mediating the therapeutic scheme of targeting anti-tumor drugs to tumor sites. The experiments of the present invention prove that the Trun3 fusion protein can be targeted to many malignant tumor tissues with high TLR4 expression, thereby improving the efficacy of antitumor drugs, reducing the side effects of antitumor drugs, and achieving the effect of targeted therapy. Trun3 was invented based on the sequence of CNB, CNB is an anti-tumor drug with good prospects, so the fragment Trun3 itself also has a certain anti-tumor effect, and has a good application prospect in the treatment of anti-tumor drugs.

Description

technical field [0001] The invention belongs to the field of biomedicine, and relates to a polypeptide sequence based on human calmodulin phosphatase B subunit and a method for using the sequence as a targeting peptide for tumor treatment. Background technique [0002] Calmodulin phosphatase is the only silk (Ser) / threonine (Thr) protein phosphatase whose activity is regulated by Ca+ / calmodulin (CaM). Calmodulin phosphatase is composed of A and B subunits in a 1:1 ratio, CNA is the catalytic subunit, and CNB is the regulatory subunit. The basic function of CNB is to regulate the catalytic activity of CNA, but more and more studies have shown that CNB has a physiological role independent of CN, and the loss of CNB increases the risk of squamous cell carcinoma. Studies in our laboratory have shown that recombinant calmodulin phosphatase B subunit (rhCNB) has a good antitumor effect and can significantly inhibit the growth of sarcoma, liver cancer, gastric cancer, lung cancer ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N9/10C12N15/54C12N15/70A61K47/64A61P35/00
CPCA61K47/64A61P35/00C12N9/1205C12N15/70C12Y207/11
Inventor 魏群杨金菊高雅丹朱紫薇秦南南
Owner BEIJING MEDINTELL BIOMED CO LTD